Crizocent (Crizotinib) 250 MG – 60 CAPSULES

(1 customer review)


Crizocent (Crizotinib) is an anti-cancer drug that inhibits kinases, hindering the growth and spread of cancer cells. It’s used in cases of locally advanced or metastatic non-small cell lung cancer (NSCLC) where the tumors are positive for anaplastic lymphoma kinase (ALK) or ROS1. Specifically, it targets lesions that are ALK-positive or ROS1-positive.

Whatsapp +8801922101029